59 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... #Pharmacology # ... Renal #Impairment #CKD
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
commonly used diabetic ... #pharmacology #dm2 ... #diabetes #medications
Diabetic Peripheral Neuropathy - Pharmacotherapy

Peripheral neuropathy is a common microvascular complication of diabetes. In clinic patients
Diabetic Peripheral ... complication of diabetes ... pregabalin as treatment ... Peripheral #Neuropathy #Diabetes ... #Pharmacology #
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... #pharmacology #pharmacotherapy ... #diabetes #endocrinology ... #treatment
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or
Metformin Treatment ... Patients With Type 2 Diabetes ... 3A, 3B, or 4 Diabetes ... #CKD4 #Dosing # ... Pharmacology #VisualAbstract
Diabetic Myonecrosis (Diabetic Muscle Infarction)
 • Spontaneous ischemic necrosis of skeletal muscle (anterior thigh or calf)
Diabetic Myonecrosis ... (Diabetic Muscle ... • Suspect in diabetic ... Common pattern: ↑CK ... weeks with above treatment
Glucose-lowering medication in type 2 diabetes - Algorithm

#Diabetes #Medications #Algorithm #Pharmacology #Pharmacotherapy #Hypoglycemic #Management #Endocrinology
medication in type 2 diabetes ... - Algorithm #Diabetes ... #Medications #Algorithm ... #Pharmacology #
Summary of Non-Insulin Agents Used to Treat Diabetes

#Diabetes #Pharmacology #Comparison #Table #Medications #Noninsulin #Orals #Agents
Used to Treat Diabetes ... #Diabetes #Pharmacology ... Comparison #Table #Medications
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Improved outcomes in CKD ... EricsMedicalLectures/featured #diabetes ... #medications #table
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
metformin in T2D and CKD ... sulfonylurea; T2D. type 2 diabetes ... type 2 diabetes; ... #Diabetes Management ... #treatment #CHART